<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03685929</url>
  </required_header>
  <id_info>
    <org_study_id>2018/0946</org_study_id>
    <nct_id>NCT03685929</nct_id>
  </id_info>
  <brief_title>Histopathological Comparison Between Superficial Pressure Ulcers and Incontinence-associated Dermatitis</brief_title>
  <official_title>Histopathological Comparison Between Superficial Pressure Ulcers and Incontinence-associated Dermatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to identify differences and similarities between superficial pressure ulcers
      (category II and III) and incontinence-associated dermatitis (category IIA) at tissue level.

      Skin biopsies will be obtained from 30 patients with pressure ulcers (n = 10),
      incontinence-associated dermatitis (n = 10), and combined lesions (n = 10).

      The results from the histopathologic examination will be compared with the clinical diagnosis
      by wound care experts, which will be based on photographs and relevant patients'
      characteristics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite current preventive strategies, prevalence of pressure ulcers and
      incontinence-associated dermatitis (IAD) is still estimated at 5.9-6.9% in hospitalised
      patients, and 5.0-5.9 in home care patients. Both skin conditions may occur in the same body
      region but are considered as separate entities, based on differences in etiology.

      At tissue level, it is assumed that pressure ulcers are characterised by ischemia and tissue
      deformation. In contrast, IAD is assumed to be characterised by an irritative pattern. These
      assumptions are reflected in current preventive strategies. However, a small scale study,
      performed by Houwing et al. (2007), described the additional presence of an ischemic pattern
      in patients with IAD. More insights into the histopathologic pattern of pressure ulcers and
      IAD is needed to optimise current preventive strategies.

      Tha aim of this study is to compare superficial pressure ulcers (category II and III) and IAD
      (category IIA) at tissue level.

      A prospective interventional study will be performed during which skin biopsies (punch
      biopsies) will be collected from 30 incontinent patients. In each patient patient, two punch
      skin biopsies will be performed, one at the border of the skin lesion and one at the adjacent
      healthy skin. Sections from the biopsies will be stained with hematoxiline and eosine and
      examined by two independently working, blinded skin pathologists. In addition, photographs
      from the skin lesions will be analysed by 10 national and international wound care experts to
      promote correct diagnosis. Finally, findings from the histopathologic examination will be
      compared with the clinical diagnoses based on photographs.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2018</start_date>
  <completion_date type="Anticipated">May 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of pressure ulcers and incontinence-associated dermatitis</measure>
    <time_frame>1 day</time_frame>
    <description>Presence of pressure ulcers and/or incontinence-associated dermatitis based on photographs and patient characteristics</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Histopathologic pattern</measure>
    <time_frame>1 day</time_frame>
    <description>Characteristics of epidermis, dermis, and subcutis based on histopathologic examination</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of agreement between visual and histopathologic diagnosis</measure>
    <time_frame>1 day</time_frame>
    <description>Agreement between diagnosis of wound care experts (based on photographs), and diagnosis by skin pathologists (based on histopathologic examination)</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pressure Ulcer</condition>
  <condition>Incontinence-associated Dermatitis</condition>
  <condition>Irritant Contact Dermatitis</condition>
  <condition>Diaper Rash</condition>
  <arm_group>
    <arm_group_label>Pressure ulcers</arm_group_label>
    <description>Patients with pressure ulcers category II/III at sacrum or trochanter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Incontinence-associated dermatitis</arm_group_label>
    <description>Patients with incontinence-associated dermatitis category IIA at sacrum (or trochanter)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined lesion</arm_group_label>
    <description>Patients with pressure ulcer category II/III and incontinence-associated dermatitis category IIA at sacrum or trochanter</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Punch skin biopsy</intervention_name>
    <description>Two punch biopsies will be performed in each patient, one at the border of the skin lesion, and one at the adjacent healthy skin. A disposable biopsy punch of 4 mm will be used. A biopsy punch is a small circular blade (like an apple corer) which is rotated into the skin to obtain a cylindrical specimen. Local anaesthesia will be applied and the circular wound will be closed by a single suture. Sutures will be removed after one week.</description>
    <arm_group_label>Combined lesion</arm_group_label>
    <arm_group_label>Incontinence-associated dermatitis</arm_group_label>
    <arm_group_label>Pressure ulcers</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Punch skin biopsy
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted on following wards of a university hospital

          -  Pneumology

          -  Gastroenterology

          -  Endocrinology

          -  Nephrology

          -  Neurology

          -  Geriatrics

          -  Gastrointestinal surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Incontinent for urine, stool, or both

          -  Superficial pressure ulcer (category II or III) and/or incontinence-associated
             dermatitis (category IIA)

          -  Expected length of stay of 7 days following punch skin biopsy

        Exclusion Criteria:

          -  Skin infection at biopsy site

          -  Medical contraindication to obtain a biopsy

          -  End of life care

          -  Not able to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sofie De Schepper</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sofie De Schepper</last_name>
    <phone>93322828</phone>
    <phone_ext>32</phone_ext>
    <email>Sofie.DeSchepper@UZGent.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ghent University Hospital</name>
      <address>
        <city>Ghent</city>
        <country>Belgium</country>
      </address>
    </facility>
    <contact>
      <last_name>Sofie De Schepper, MD/PhD</last_name>
      <email>Sofie/DeSchepper@UZGent.be</email>
    </contact>
    <investigator>
      <last_name>Hilde Beele, MD/PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dimitri Beeckman, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Liesbeth Ferdinande, MD/PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Creytens, MD/PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ann-Sophie De Vos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steven Smet, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nele Van Damme, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>http://www.UCVVGent.be</url>
    <description>Website of the research group</description>
  </link>
  <reference>
    <citation>Beeckman D, Van Damme N, Schoonhoven L, Van Lancker A, Kottner J, Beele H, Gray M, Woodward S, Fader M, Van den Bussche K, Van Hecke A, De Meyer D, Verhaeghe S. Interventions for preventing and treating incontinence-associated dermatitis in adults. Cochrane Database Syst Rev. 2016 Nov 10;11:CD011627. Review.</citation>
    <PMID>27841440</PMID>
  </reference>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>September 24, 2018</study_first_submitted>
  <study_first_submitted_qc>September 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2018</study_first_posted>
  <last_update_submitted>October 2, 2018</last_update_submitted>
  <last_update_submitted_qc>October 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pressure ulcer</keyword>
  <keyword>Incontinence-associated dermatitis</keyword>
  <keyword>Histopathology</keyword>
  <keyword>Ischemia</keyword>
  <keyword>Irritation</keyword>
  <keyword>Prevention</keyword>
  <keyword>Tissue</keyword>
  <keyword>Skin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Pressure Ulcer</mesh_term>
    <mesh_term>Dermatitis, Contact</mesh_term>
    <mesh_term>Diaper Rash</mesh_term>
    <mesh_term>Dermatitis, Irritant</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

